Related Experiment Video
Updated: Jan 9, 2026
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Fecal Contamination Leading to Falsely Elevated Urinary Amylase: Insights into Pre-analytical Quality Control
Background:
Elevated urinary amylase is usually associated with pancreatic disease, but non-pancreatic factors such as fecal contamination can also lead to false elevation.
Methods:
The retrospective analysis of a 75-year-old patient with acute cerebral infarction identified fecal contamination as the cause of falsely elevated urinary amylase.
Results:
Initial urine test showed amylase > 24,000 U/L, the level of which decreased to 164 U/L after standardized urine collection. Abdominal CT confirmed normal pancreatic morphology and uniform density.
Conclusions:
Fecal contamination is the key source of falsely elevated urinary amylase. Strict pre-analytical quality control is the key to preventing laboratory errors.
Insights
Fecal contamination can falsely elevate urinary amylase levels, mimicking pancreatic disease. Standardized urine collection is crucial for accurate diagnostic testing and preventing laboratory errors.
Area of Science:
- Clinical Chemistry
- Diagnostic Laboratory Medicine
Background:
- Elevated urinary amylase typically suggests pancreatic disease.
- Non-pancreatic sources, like fecal contamination, can cause inaccurate elevations.
- Distinguishing true pancreatic indicators from contaminants is clinically important.
